Irccs San Raffaele Roma S.r.l. — Clinical Trial Site

38 Registered trials

16 Currently recruiting

Organisation

Irccs San Raffaele Roma S.r.l.

Location

Rome, Italy

Identifier

ORG-100029280

Address

Via Olgettina 58, 20132, Italy

Departments

#40534: Centro Parkinson, parkinsonismi e disturbi del movimento
Cardio-Pulmonary Department
Cardiology
Cardiopulmonary Rehabilitation
Centro Diagnosi e Terapia della cefalea e del dolore
Centro per la cura e la diagnosi del Parkinson
Clinical Trial Center
Clinical Trial Center Parkinson
Department of Neurology
Department of Neurology - Via di Val Cannuta 250, Rome, 00166
Department of Neurology – Clinical Trial Center
Dipartimento area Cardiorespiratoria
Dipartimento di Neurologia
Dipartimento di Neurologia -Unità per la cura e la ricerca su cefalee e dolore
Gastroenterology
IRCCS San Raffaele - Department of Neurology - Via di Val Cannuta 250, Rome, 00166
Medical Oncology
N/A
Neurology
Parkinson Disease Center
Parkinson’s center, parkinsonism and movement disorders
Research Facility
Riabilitazione Cardiologica
San Raffaele Cassino - Parkinson Disease Center
Unità Cefalee e Dolore
Unità per la cura e la ricerca su cefalee e dolore
Unità per la cura e la ricerca su cefalee e dolore - Dipartimento di Neurologia
Unità per la cura e la ricerca su Cefalee e dolore, Dipartimento di Neurologia
UO Endoclinologia

Clinical trials at this site (38)

Search interface

A Phase 2 Study of NEU-411 in Companion Diagnostic-Positive Participants with Early Parkinson’s Disease Pending

2024-515448-22-00 Parkinson 4
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease Pending

2025-521113-13-00 Early Parkinson’s Disease 10
A study to investigate efficacy, safety, immunogenicity, and pharmacokinetics of GSK3862995B following repeat doses in participants with bro… Recruiting

2025-522892-27-00 Bronchiectasis 4 2026-03-21
Evaluation of the efficacy and safety of eneboparatide (AZP-3601) in patients with chronic hypoparathyroidism (CALYPSO) Recruiting

2022-503126-12-01 Hypoparathyroidism 5 2024-01-05
HF-POLARIS: A research study to look at how well NNC0487-0111 works compared to placebo in people with heart failure and obesity Recruiting

2025-523717-29-00 HFpEF or HFmrEF and obesity 5 2026-04-28
An Open-Label Extension, Multi-Centered, Phase 2 Trial of TEV-56286 (Emrusolmin) for Multiple System Atrophy Recruiting

2025-521642-14-00 Multiple System Atrophy 4 2026-03-05
A Study to Compare the Efficacy and Safety of Prasinezumab with a placebo in Participants with Early-Stage Parkinson’s Disease Recruiting

2025-522683-32-00 Early-Stage Parkinson’s Disease (PD) 5 2026-01-15
A trial to learn how well AZD0292 works, how safe it is, and how it moves throughout the body over time in people with bronchiectasis and ch… Recruiting

2025-523009-14-00 Bronchiectasis with chronic pseudomonas aeruginosa colo 4 2025-12-16
A study to investigate the safety and efficacy of MEDI0618 compared to placebo in adult participants with episodic migraine Recruiting

2024-512904-21-00 Migraine 4 2025-12-10
A Phase 3b open-label, randomised study of IPX203 in subjects with advanced Parkinson’s disease and motor fluctuations - ADIP study Recruiting

2025-521772-57-00 Motor fluctuations in advanced Parkinson’s disease 5 2025-11-06
C4951063: A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine Recruiting

2024-517121-10-00 Menstrual Migraine 5 2025-10-17
A clinical trial to evaluate efficacy and safety of Xeomin® injections for preventing chronic migraine Recruiting

2024-515682-34-00 Chronic migraine 5 2025-10-06
A clinical trial to evaluate efficacy and safety of Xeomin® injections for preventing episodic migraine Recruiting

2024-515715-22-00 Episodic migraine 5 2025-10-06
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction Recruiting

2024-519219-32-00 Heart Failure With Reduced Ejection Fraction 5 2025-06-23
A Multi-centered, Double-blind, Randomized, Placebo-controlled Study of TEV-56286 for the Treatment of Multiple System Atrophy Recruiting

2023-505320-54-00 Multiple System Atrophy 4 2025-01-30
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Migraine Prevention in Ch… Recruiting

2024-512382-13-00 Migraine (with or without aura) 5 2022-10-04
Prevention of postoperative endoscopic disease recurrence in Crohn’s disease: a multicentric study that compares the systematic start of bio… Recruiting

2022-500311-39-00 Patients with Crohn's disease undergoing surgery and ha 6 2022-09-08
Phase 2 Study of CVN424 Ended

2024-516811-25-00 Parkinson Disease 4 2025-05-15
AN INTERVENTIONAL, EFFICACY, AND SAFETY, PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH AN OPEN-LABEL EXTENSION TO INVESTI… Ended

2023-505601-16-00 Chronic Migraine 5 2025-04-22
PROSPER: clinical Phase 2 study to test how safe and effective is a new medicine called FNP-223 to slow disease progression of progressive s… Ended

2023-510366-28-00 Progressive supranuclear palsy (PSP) 4 2024-09-25
A study to evaluate the effectiveness and safety of Dysport® for the prevention of chronic migraine in adults Ended

2023-504827-17-00 Chronic migraine 5 2024-03-18
A study of sigvotatug vedotin versus docetaxel in previously treated non-small cell lung cancer (Be6A Lung-01) Ended

2023-503827-25-01 Non-Small Cell Lung Cancer (NSCLC) 5 2024-02-16
Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events and Disease Activity in Adult Participants With Migraine… Ended

2022-501172-25-00 Chronic and Episodic Migraine 5 2024-01-17
An international randomized clinical study, measuring safety and effectiveness of basimglurant for the treatment of pain in patients with Tr… Ended

2024-514497-41-00 Trigeminal neuralgia 10 2022-03-24